2Indexed trials
drug · Product Intelligence
Bupropion
Pipeline Intelligence
Bupropion: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT01892813Mark Vander Weg · depressionPHASE3
NCT04553263University of California, Los Angeles · adhdEARLY_PHASE1
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2026-05-04
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2025-05-02
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2017-11-03
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2014-10-31
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2013-10-11
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2013-10-11
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2008-08-15
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2007-06-13
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2004-05-27
FDA_APPROVALBUPROPION HYDROCHLORIDE · 2004-03-22
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.